Dr Daniel Patterson: Medical oncology
Search
Search for Bupa recognised healthcare professionals and facilities.
+ any details

Dr Daniel Patterson

Medical oncology

  • Fee assured
Overview

About me

Experienced specialist in the systemic treatment of lung, gastrointestinal malignancies and carcinoma unknown primary. Particular interest in immunotherapies and molecular targeted therapies. Underwent training in London and obtained CCT in medical oncology in 2009. My aim is to always provide patients a balanced and tailored approach to their situation, and to explore all options available.

Areas of interest

Lung cancer; mesothelioma; oesophageal/gastric cancer; pancreatic cancer; small bowel cancer; cholangiocarcinoma; colorectal cancer; neuroendocrine tumours; cancer of unknown primary (CUP).

Medical secretaries

About me
My qualifications & training
My private practice
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

  • X0003

    Clinical supervision and planning for delivery of chemotherapy cycle 1 - 21 days - (5-50)

  • X0002

    Clinical supervision and planning for delivery of chemotherapy cycle 1 - 14 days - (5-50)

  • X0004

    Clinical supervision and planning for delivery of chemotherapy cycle 1 - 28 days - (5-50)

  • AA844

    Clinical supervision and planning for delivery of chemotherapy cycle in the member's home 1-28 days - (5-50)

  • AA842

    Clinical supervision and planning for delivery of chemotherapy cycle in the member's home 1-14 days - (1-5)

Edit details Print page

The information contained on Finder is submitted by consultants, therapists and facilities, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the data and information on Finder and our website terms of use here.